tiprankstipranks
Crispr Therapeutics AG Advances Governance and Incentives
PremiumCompany AnnouncementsCrispr Therapeutics AG Advances Governance and Incentives
29d ago
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
PremiumPress Releases
CRISPR Therapeutics to Participate in Upcoming Investor Conferences
1M ago
Crispr Therapeutics appoints Patel as CMO, Bruno as COO
PremiumThe Fly
Crispr Therapeutics appoints Patel as CMO, Bruno as COO
1M ago
Crispr Therapeutics price target lowered to $95 from $102 at Oppenheimer
PremiumThe FlyCrispr Therapeutics price target lowered to $95 from $102 at Oppenheimer
2M ago
CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference
PremiumPress Releases
CRISPR Therapeutics to Present at the Bank of America Securities Health Care Conference
2M ago
Crispr Therapeutics price target lowered to $65 from $70 at Wells Fargo
PremiumThe Fly
Crispr Therapeutics price target lowered to $65 from $70 at Wells Fargo
2M ago
Crispr Therapeutics management to meet with Mizuho
PremiumThe FlyCrispr Therapeutics management to meet with Mizuho
2M ago
Crispr Therapeutics management to meet with Mizuho
PremiumThe Fly
Crispr Therapeutics management to meet with Mizuho
2M ago
CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
PremiumPress Releases
CRISPR Therapeutics to Present Oral Presentation at the American Society of Gene & Cell Therapy (ASGCT) 2024 Annual Meeting
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100